CAS RN: 18717-73-2
8-BENZYL-8-AZABICYCLO[3.2.1]OCTAN-3-ENDO-OL
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20260119 |
1g / 5g |
Out of stock |
5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 0.1g, 0.25g, 5g, 10g, 25g
- Available purity: >97%
- Inventory rows with stock: 6
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 18717-73-2
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
>97% |
5
In Stock
|
Hong Kong |
Inquiry |
| 0.1g |
>97% |
4
In Stock
|
Shanghai |
Inquiry |
| 0.25g |
>97% |
4
In Stock
|
Hong Kong |
Inquiry |
| 5g |
>97% |
4
In Stock
|
Beijing |
Inquiry |
| 10g |
>97% |
4
In Stock
|
Shanghai |
Inquiry |
| 25g |
>97% |
4
In Stock
|
Hong Kong |
Inquiry |
18717-73-2 / (1S,5R)-8-benzyl-8-azabicyclo[3.2.1]octan-3-ol
Standard CAS: 18717-73-2
Multi CAS: No
Basic Information
CAS
18717-73-2
Multi CAS
No
Molecular Formula
C14H19NO
Molecular Weight
217.310000
Exact Mass
217.146664
SMILES
C1C[C@H]2CC(C[C@@H]1N2CC3=CC=CC=C3)O
InChI
InChI=1S/C14H19NO/c16-14-8-12-6-7-13(9-14)15(12)10-11-4-2-1-3-5-11/h1-5,12-14,16H,6-10H2/t12-,13+,14?
InChIKey
HCBGIBWAPOFRKI-PBWFPOADSA-N
Computed Properties
Structural Parameters
Heavy atom count
16
Aromatic heavy atom count
6
Fraction Csp3
0.57
Rotatable bonds
2
H-bond acceptors
2
H-bond donors
1
Molar refractivity
64.04
TPSA
23.47
LogP / Solubility
WLOGP
2.17
MLOGP
1.92
XLogP3
2.2
Consensus LogP
2.1
Log S (ESOL)
-2.7
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.91
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-3.12
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.5
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
4.5